Xcelience has opened a new 24,000-sq.-ft. facility in Tampa dedicated to primary and secondary packaging, labeling, distribution and warehouse services. Xcelience offers cGMP services from pre-formulation and formulation through clinical manufacturing and clinical supplies for Phase I-III trials. This is the company's second facility in the Tampa Bay area, and is audited and approved for domestic and European trials. Xcelience has approximately 100 employees and with the new plant, it plans to double its headcount during the next three years.
“At Xcelience, we work on several dozens of molecules, each of which has the potential to radically improve people's lives,” said Derek Hennecke, chief executive officer and president. “We love being in Tampa, because through USF, UF and Tampa's growing biotech community, we have access to scientists at the height of their field. We don't have to go far to find people who thrive on the challenge of working with different molecules, upholding rigorous FDA standards while also demonstrating the agility to meet client parameters for speed, cost and efficiency.”